These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1214 related items for PubMed ID: 16808908

  • 1. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 2. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 3. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009 Jun; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 4. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 5. [Role of Fas-FasL and caspase-3 signal transduction pathway in promoting apoptosis of T lymphocyte subset in SLE patients].
    Chen X, Wang LL, Cai B, Chen J, Feng WH.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):588-90. PubMed ID: 16948902
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T.
    Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
    [Abstract] [Full Text] [Related]

  • 7. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V, Singh AP, Aggarwal A, Naik S, Misra R.
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [Abstract] [Full Text] [Related]

  • 8. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, Gorochov G.
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [Abstract] [Full Text] [Related]

  • 9. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 10. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL.
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [Abstract] [Full Text] [Related]

  • 11. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL.
    Clin Cancer Res; 2005 Feb 01; 11(3):1010-20. PubMed ID: 15709166
    [Abstract] [Full Text] [Related]

  • 12. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
    Cipriani P, Fulminis A, Pingiotti E, Marrelli A, Liakouli V, Perricone R, Pignone A, Matucci-Cerinic M, Giacomelli R.
    J Rheumatol; 2006 Oct 01; 33(10):2003-14. PubMed ID: 17014016
    [Abstract] [Full Text] [Related]

  • 13. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y.
    Hokkaido Igaku Zasshi; 1997 Jul 01; 72(4):443-55. PubMed ID: 9266252
    [Abstract] [Full Text] [Related]

  • 14. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
    Chen DY, Hsieh TY, Hsieh CW, Lin FJ, Lan JL.
    Arthritis Rheum; 2007 Dec 15; 57(8):1530-8. PubMed ID: 18050226
    [Abstract] [Full Text] [Related]

  • 15. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E, Puccetti A, Gerli R, Rigo A, Migliorini P, Simeoni S, Beri R, Dolcino M, Martinelli N, Corrocher R, Lunardi C.
    Int Immunol; 2009 Mar 15; 21(3):237-43. PubMed ID: 19181929
    [Abstract] [Full Text] [Related]

  • 16. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
    Li B, Bassiri H, Rossman MD, Kramer P, Eyuboglu AF, Torres M, Sada E, Imir T, Carding SR.
    J Immunol; 1998 Aug 01; 161(3):1558-67. PubMed ID: 9686624
    [Abstract] [Full Text] [Related]

  • 17. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
    Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C.
    J Rheumatol; 2007 Jul 01; 34(7):1580-4. PubMed ID: 17516614
    [Abstract] [Full Text] [Related]

  • 18. [Study of fas-mediated Foxp3+CD4+CD25+ Treg cell apoptosis in patients with systemic lupus erythematosus].
    Lin XJ, Luo M, Cai XY.
    Zhonghua Yi Xue Za Zhi; 2011 Mar 08; 91(9):586-90. PubMed ID: 21600126
    [Abstract] [Full Text] [Related]

  • 19. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH, Shen Q, Zhao DB, Cai Q, Han XH.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 02; 85(5):318-23. PubMed ID: 15854508
    [Abstract] [Full Text] [Related]

  • 20. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ, Ku JK, Kim MY, Kang H, Cho SH, Kim HO, Park YM.
    Br J Dermatol; 2006 Mar 02; 154(3):419-25. PubMed ID: 16445769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.